Canopy Growth publishes FY2026 annual report

• Canopy Growth filed its fiscal 2026 annual report, highlighting progress from a tighter operating focus and a stronger commercial platform.
• Canadian medical cannabis strengthened, adult-use returned to growth, international medical expanded as regulatory frameworks evolved in Europe and Australia.
• Completed the acquisition of MTL Cannabis on March 16, 2026, positioning the company as Canada’s top medical cannabis provider by revenue.
• Storz & Bickel shifted to a refreshed plan centered on U.S. sales and marketing, product innovation, supply chain optimization.
• Balance sheet actions included a US$150 million senior secured term loan, repaid the prior first lien term loan facility.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Canopy Growth Corp. published the original content used to generate this news brief on August 21, 2026, and is solely responsible for the information contained therein.